New single institution study suggests HIGHER rates of BRCA1/2 mutations in Hispanic women with breast cancer. Specifically, a study of 2401 unselected breast cancer patients showed that Hispanic women were more than 2.5 times more likely to have a BRCA1/2 mutation compared to non-Hispanic women. BRCA1/2 mutations were found in: These findings show the importance …
Permanent link to this article: https://inheritedcancer.net/post-10212025/
A recent study found that non-Hispanic Black and Hispanic women are underrepresented in clinical trials evaluating PARP inhibitor use among ovarian cancer patients; therefore, these trials do not accurately represent the ovarian cancer patient population. These findings indicate initiatives to increase diversity in clinical trials are needed. Read the full article for more information ๐https://www.gynecologiconcology-online.net/article/S0090-8258(22)00071-3/fulltext#secst0030Reference: …
Permanent link to this article: https://inheritedcancer.net/post42222/
